The NPA said it issued the brief guide “in the light of growing concerns about a lack of publicly available information from official channels”. The Directive, which is aimed at tackling counterfeit medicines in the supply chain, comes into force on 9 February 2019.
NPA board member Raj Patel said: “As it stands, we are still awaiting crucial details from the government about the position post-Brexit and assurances on funding. This means that the pharmacy sector can’t yet make major investment decisions in relation to FMD. In turn, this makes a February 2019 implementation date challenging, to say the least. Unless the government fills the information gap soon, a challenging deadline will become an impossible deadline.”
The NPA advises contractors to check the FMD Source website for updates.